Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310398 · ClinicalTrials.gov registry record
Negative-Positive Valence Domains in Anxiety and Depression
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 248
- Enrollment target
NCT03310398: Completed study, sponsored by University of California, San Diego.
NCT03310398 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03310398 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
Anxiety and depression are highly prevalent and disabling conditions that frequently co-occur, and are costly to the individual and society. Despite important advances in our understanding of these disorders, there is a significant unmet need to identify reliable and clinically useful tests that can predict prognosis, inform treatment choice for a given individual, and improve treatment outcomes. The aim of this project is to fill this critical gap by validating a battery of measures including brain imaging, psychophysiology, behavior, and self-report that will reliably assess positive and negative affect, or valence, system functioning in a broad sample of individuals screened for anxiety and depression as part of their routine primary care visits.
Primary Outcome
Measure of BOLD % signal difference in brain regions of interest during reward or loss trials for anticipation and outcome phases in a reward paradigm, and conditioning trials in a fear conditioning paradigm.
Interventions
- BEHAVIORAL NeuroImaging
- BEHAVIORAL Psychophysiological
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2013-09-01 |
| Est. Completion | 2017-06-30 |
What the finished NCT03310398 record still lists
NCT03310398 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which NeuroImaging is the first listed.
NCT03310398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03310398 about?
NCT03310398 is a clinical study titled "Negative-Positive Valence Domains in Anxiety and Depression". Anxiety and depression are highly prevalent and disabling conditions that frequently co-occur, and are costly to the individual and society. Despite important advances in our understanding of these disorders, there is a significant unmet need to identify reliable and clinically useful tests that can...
What is the current status of trial NCT03310398?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2013-09-01. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT03310398?
The interventions under investigation include: NeuroImaging (BEHAVIORAL), Psychophysiological (BEHAVIORAL).
Who is sponsoring clinical trial NCT03310398?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI